Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn’s disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.

Study reveals how salt-based nicotine and menthol flavors influence e-cigarette use in young adults

Study found that salt-based nicotine and menthol flavoring in e-cigarettes significantly increase nicotine levels and positive experiences among young adults, potentially heightening addiction risks.

August 14, 2024

Meta Title: Arcturus Therapeutics Files Patent for Modified Human OTC Protein

Share this article According to GlobalData’s company profile on Arcturus Therapeutics, Nanoparticle drug conjugates was a key innovation area identified from patents. Arcturus Therapeutics‘s grant

March 26, 2024

Eli Lilly’s tirzepatide is the king of the GLP-1s, but other options are coming

Eli Lilly’s tirzepatide is still the most effective weight-loss treatment to date, according to detailed data from its Phase III SURMOUNT-2 study released at the

June 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.